MODIFICATION OF IMMUNE SYSTEM BY CHRONIC HCV INFECTION AND UNIQUE PREDICTORS OF EARLY ACUTE REJECTION AFTER HCV LIVER TRANSPLANTATION VERSUS NON HCV LIVER TRANSPLANTATION

被引:0
|
作者
Koshiba, Takaaki [1 ]
Zhao, Xiangdong [2 ]
Li, Ying [2 ]
Bishop, Alex [3 ]
机构
[1] Fukushima Med Univ, Dept Disaster & Comprehens Med, Fukushima, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan
[3] Royal Prince Alfred Hosp, Transplantat Lab, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:208 / 208
页数:1
相关论文
共 50 条
  • [21] Prospective randomized trial on early treatment of HCV infection after liver transplantation in HCV-RNA positive patients
    Mazzaferro, V
    Schiavo, M
    Caccamo, L
    Tagger, A
    Morabito, A
    Lavezzo, B
    Antonucci, A
    Bonino, F
    LIVER TRANSPLANTATION, 2003, 9 (06) : C36 - C36
  • [22] Liver transplantation from old donors into HCV and non-HCV recipients
    Baccarani, U
    Adani, GL
    Toniutto, P
    Sainz, M
    Lorenzin, D
    Viale, PL
    Ramacciato, G
    Risaliti, A
    Bresadola, F
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 527 - 528
  • [23] Elderly donors in HCV versus non-HCV recipients - Patient survival following liver transplantation
    Boin, Ilka F. S. F.
    Stucchi, Raquel
    Leonardi, Marilia I.
    Pereira, Tiago S.
    Cardoso, Adilson R.
    Caruy, Cristina A.
    Luso, Angela
    Leonardi, Luiz S.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 108 - 109
  • [24] Early lobular necrosis and living donor liver transplantation are strong predictors of severe HCV recurrence after liver transplantation.
    Garcia-Retortillo, M
    Forns, X
    Llovet, JM
    Navasa, M
    Turnes, J
    Garcia-Pagan, JC
    Bosch, J
    Fuster, J
    Garcia-Valdecasas, JC
    Rimola, A
    HEPATOLOGY, 2003, 38 (04) : 530A - 530A
  • [25] Predictors of Liver Fibrosis in Patients with Chronic HCV Infection
    Ceylan, Bahadir
    Yardimci, Cem
    Fincanci, Muzaffer
    Tozalgan, Umit
    Eren, Gulhan
    Muderrisoglu, Cuneyt
    Inci, Ayse
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (06): : 1522 - 1529
  • [26] Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation
    van den Berg, AP
    Haagsma, EB
    Gouw, ASH
    Slooff, MJH
    Jansen, PLM
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1467 - 1467
  • [27] Rejection treatment modifies HCV quasispecies evolution after liver transplantation.
    Arenas, JI
    Laskus, T
    Wilkinson, J
    Gallegos, JF
    Fasola, CG
    Adair, D
    Radowski, M
    Kibler, KV
    Douglas, D
    Williams, J
    Netto, G
    Mulligan, D
    Klintmalm, G
    Rakela, J
    Vargas, HE
    HEPATOLOGY, 2003, 38 (04) : 532A - 532A
  • [28] Influence or rejection treatment on outcome in patients with HCV related liver disease after liver transplantation
    Neumann, UP
    Langrehr, JM
    Bechstein, WO
    Lang, M
    Neuhaus, P
    TRANSPLANTATION, 1999, 67 (07) : S197 - S197
  • [29] Early PTLD of the liver and bile duct after liver transplantation for HCV related cirrhosis
    Como, Vittorio
    Lucianetti, Alessandro
    Sonzogni, Aurelio
    Rambaldi, Alessandro
    Guizzetti, Michela
    Pinelli, Domenico
    Zambelli, Marco
    Dezza, Maria Clara
    Gaffuri, Giovanna
    Tebaldi, Atessandra
    Strazzab-osco, Mario
    Fagiuoli, Stefano
    TRANSPLANT INTERNATIONAL, 2008, 21 : 5 - 5
  • [30] Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens
    Papatheodoridis, GV
    Barton, SGRG
    Andrew, D
    Clewley, G
    Davies, S
    Dhillon, AP
    Dusheiko, G
    Davidson, B
    Rolles, K
    Burroughs, AK
    GUT, 1999, 45 (03) : 427 - 434